(Date:12/2/2008)... , National Non-profit La...that Provides Eye Exams at No Cost to Eligible Pat... San Francisco, CA (Vocus) December 2...eniors who suffer with an eye disease known as Age...always, "No.", , , , ,Picture this&hell...
(Date:12/2/2008)... , Liberty Mutual Provide...ms at www.BeFireSmart.com , ...ty Mutual Insurance and Holly Robinson Peete , a...ming up to encourage families to set aside a few m...ty precautions and response plans at BeFireSmart.c...
(Date:12/1/2008)... SOUTH BEND, Ind., Dec. 2 Patient...cilities are on the rise according to a new report...atient Pulse Report: Patient,Perspectives on Amer...,facilities as a driver for improvement in patien...ore than 2 million patients treated at more than,...
(Date:12/1/2008)... , CHICAGO New research has found that the avail...phy (CT) scanner in an emergency room can signific...ceive a potentially life-saving treatment. Results...nter (NSMC)-Salem Hospital in Salem, Mass., will b...iological Society of North America (RSNA). , "T...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2...07 – On 23 July SYGNIS Pharma,AG will presen...AX200 (AXIS-study)., AX200, a compound for the tre...ate in SYGNIS’ product pipeline. The,primary...ty of,AX200 in acute stroke patients. The results ...ion for the further clinical,development of AX200....
...swire-FirstCall/ -- ImClone,Systems Incorporated a...sults from an open-label Phase III study of ERBITU...the first-line,treatment for metastatic non-small ...ts primary endpoint of progression-free,survival (...w,committee (IRRC). However, key secondary endpoin...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9Solid 8 mm blades. Dull finish. Most popular size or model.
Open 10 mm blades. Dull finish.
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model.
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: